MARKET IS CLOSED
Loading latest tickers...
Market Indices
S&P 500
$7,722.72
+0.73%
NASDAQ 100
$30,807.93
+1.00%
DOW JONES
$51,177.00
+0.49%
NASDAQ Composite
$27,190.86
+1.19%
RUSSELL 2000
$2,815.20
+0.90%
CBOE VIX
$15.31
-6.59%
Sector Heatmap
Technology+1.01%
Financials+0.06%
Healthcare-0.01%
Consumer Cycl+1.13%
Consumer Staples+0.25%
Energy+0.40%
Industrials+0.78%
Materials+0.66%
Real Estate+0.32%
Utilities+0.38%
Comm Services+0.35%
FBLG — FibroBiologics, Inc. Common Stock
NasdaqFibroBiologics, Inc. Common Stock
$1.24
+0.04(+2.90%)
- O
- 1.20
- H
- 1.24
- L
- 1.10
- V
- 147.71K
⏱️ End-of-day dataAs of Oct 2, 2026
Chart
About FBLG
FibroBiologics Inc a clinical-stage biotechnology company focused on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with unmet medical needs, including wound healing, multiple sclerosis, or MS, degenerative disc disease, psoriasis, certain cancers, and potential human longevity applications including thymic involution reversal using a thymic organoid. Its product candidates are CYWC628, CYPS317, CYMS101 and CybroCell.
IndustryPHARMACEUTICAL PREPARATIONS
SectorNot available
IPO DateJan 31, 2024
Employees15
Stock ExchangeNasdaq
Ticker SymbolFBLG
Key Financial Statistics
| Market Cap | $8.63M |
| P/E Ratio | N/A |
| Dividend Yield | None |
| EPS | N/A |
| Beta | N/A |
| 52-Week Range | $0.62 - $11.40 |
| 52-Week Avg Volume | 212.0K |
| VWAP | $1.16 |
| Transactions | 760 |
| Total Recorded Bars | 671 days |